Loading insider details...
Beta
Latest Form 4 (May 21, 2026): Grant/Award of 762,200 UNCY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 21, 2026 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 762,200 | n/a |
| Jul 30, 2025 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 325,000 | n/a |
| Aug 14, 2024 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 232,868 | n/a |
| Apr 17, 2024 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 1,319,583 | n/a |
| Aug 30, 2023 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 4,684,775 | n/a |
| Jul 13, 2023 | Unicycive Therapeutics, Inc. (UNCY) | Exercise/Conversion | 104,612 | n/a |
| Mar 10, 2023 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 50 | $50.0K |
| Nov 23, 2022 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 86,000 | n/a |
| Jul 26, 2021 | Unicycive Therapeutics, Inc. (UNCY) | Grant/Award | 116,279 | n/a |